229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults

✍ Scribed by I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin; D. George; M.B. Bradley; P. Satwani; J. Schwartz; K. Wolownik; S. Foley; R. Hawks; Z.Z. Jin; L.A. Baxter-Lowe; C. van de Ven; M.S. Cairo

• Book ID: 116280056
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 60 KB
• Volume: 14
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2007.12.238